Please login to the form below

Not currently logged in
Email:
Password:

Tremfya

This page shows the latest Tremfya news and features for those working in and with pharma, biotech and healthcare.

AbbVie lauds head-to-head win for Skyrizi versus Cosentyx

AbbVie lauds head-to-head win for Skyrizi versus Cosentyx

On paper Skyrizi is actually a closer competitor to Johnson &Johnson's Tremfya (guselkumab), which also targets IL-23, but there’s little doubt that – sales-wise at least – Cosentyx is ... Tremfya, which made $742m for J&J in the first nine months

Latest news

More from news
Approximately 9 fully matching, plus 18 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

Emotion-driven clinical trial marketing: A missed opportunity?
Whether we’re conscious of it or not, our emotions play a huge role in day-to-day decision making. Psychological scientists have long explored emotional influences on decision making. Experts like Herbert...
Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...

Infographics